Previous Next Low-value Care The Covid-19 Plasma Boom Is Over. What Did We Learn From It? Abstract: The U.S. government invested $800 million in plasma when the country was desperate for Covid-19 treatments. A year later, the program has fizzled. Publication: The New York Times Date Published: April 17, 2021 Author(s): Katie Thomas and Noah Weiland View This Resource